33,000 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Bought by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB purchased a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 33,000 shares of the company's stock, valued at approximately $1,040,000. E. Ohman J or Asset Management AB owned approximately 0.06% of Astrana Health as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. State Street Corp acquired a new position in Astrana Health in the third quarter worth about $91,966,000. Geode Capital Management LLC acquired a new position in shares of Astrana Health in the 3rd quarter worth approximately $58,995,000. FMR LLC bought a new position in shares of Astrana Health during the 3rd quarter worth approximately $48,413,000. SteelPeak Wealth LLC bought a new position in shares of Astrana Health during the 3rd quarter worth approximately $39,398,000. Finally, Loomis Sayles & Co. L P acquired a new stake in Astrana Health in the 3rd quarter valued at $30,251,000. Institutional investors own 52.77% of the company's stock.

Astrana Health Trading Up 0.6 %

ASTH traded up $0.20 during mid-day trading on Friday, reaching $35.78. The stock had a trading volume of 211,638 shares, compared to its average volume of 347,777. The stock has a market capitalization of $2.01 billion, a P/E ratio of 27.52, a P/E/G ratio of 1.37 and a beta of 1.20. Astrana Health, Inc. has a 52 week low of $29.08 and a 52 week high of $63.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The firm's fifty day simple moving average is $35.61 and its two-hundred day simple moving average is $45.89.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts' consensus estimates of $0.33. The firm had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period last year, the company earned $0.47 earnings per share. On average, equities analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have issued reports on ASTH shares. Robert W. Baird lifted their price objective on Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a report on Wednesday, November 13th. Macquarie raised shares of Astrana Health to a "hold" rating in a report on Monday, December 16th. TD Cowen initiated coverage on shares of Astrana Health in a research report on Monday, October 14th. They issued a "buy" rating and a $66.00 price target on the stock. Finally, Truist Financial dropped their price objective on shares of Astrana Health from $59.00 to $50.00 and set a "buy" rating for the company in a report on Monday, January 13th. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $63.67.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.